ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 133 filers reported holding ARRAY BIOPHARMA INC in Q3 2013. The put-call ratio across all filers is 16.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $15,000 | -75.0% | 1,007 | -78.4% | 0.00% | -87.5% |
| Q4 2017 | $60,000 | -82.9% | 4,658 | -83.7% | 0.01% | -72.4% |
| Q3 2017 | $351,000 | +5750.0% | 28,518 | +4362.9% | 0.03% | +2800.0% |
| Q1 2017 | $6,000 | -92.7% | 639 | -93.2% | 0.00% | -88.9% |
| Q4 2016 | $82,000 | +241.7% | 9,402 | +67.2% | 0.01% | +125.0% |
| Q4 2015 | $24,000 | +60.0% | 5,624 | +67.5% | 0.00% | +300.0% |
| Q3 2015 | $15,000 | -91.6% | 3,358 | -86.5% | 0.00% | -93.8% |
| Q2 2015 | $178,000 | +191.8% | 24,812 | +198.3% | 0.02% | +100.0% |
| Q1 2015 | $61,000 | +6000.0% | 8,319 | +4059.5% | 0.01% | – |
| Q4 2014 | $1,000 | -90.9% | 200 | -93.7% | 0.00% | -100.0% |
| Q3 2014 | $11,000 | -52.2% | 3,187 | -36.3% | 0.00% | -66.7% |
| Q2 2014 | $23,000 | -58.9% | 5,000 | -58.0% | 0.00% | -57.1% |
| Q1 2014 | $56,000 | +47.4% | 11,891 | +53.4% | 0.01% | +16.7% |
| Q4 2013 | $38,000 | -59.6% | 7,752 | -48.6% | 0.01% | -40.0% |
| Q3 2013 | $94,000 | +9300.0% | 15,082 | +5569.9% | 0.01% | – |
| Q2 2013 | $1,000 | – | 266 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Advisory Services Network, LLC | 3,442 | $159,000 | 0.01% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |